Similarly, the use of inhibitors of various pro-factors such as IL-4, IL-10, TGF-β and IL-13 may reduce the migration of TAMs toward the tumor microenvironment to a certain extent [135–137]. This evidence concerns the gene TGFB1 and neoplasm.